Axsome Therapeutics Overview

  • Founded
  • 2012
Founded
  • Status
  • Public
  • Employees
  • 60
Employees
  • Stock Symbol
  • AXSM
Stock Symbol
  • Share Price
  • $50.32
  • (As of Monday Closing)

Axsome Therapeutics General Information

Description

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and others.

Contact Information

Website
axsome.com
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Other Healthcare Services
Stock Exchange
NAS
Primary Office
  • 25 Broadway
  • 9th Floor
  • New York, NY 10004
  • United States
+1 (212) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Axsome Therapeutics Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$50.32 $48.59 $48.34 - $90.00 $1.83B 37.6M 361K -$2.66

Axsome Therapeutics Financials Summary

In Thousands,
USD
TTM 31-Mar-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 1,984,134 2,888,098 3,780,654 76,578
Revenue 0 0 0 0
EBITDA (95,344) (100,257) (67,068) (29,789)
Net Income (99,676) (102,901) (68,345) (30,965)
Total Assets 166,904 186,134 220,550 15,379
Total Debt 50,124 50,124 19,935 6,911
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Axsome Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Axsome Therapeutics‘s full profile, request access.

Request a free trial

Axsome Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for t
Biotechnology
New York, NY
60 As of 2020
000.00
0000 0000-00-00
00000000 000.00

00000000

odo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugia
0000000000000
Cambridge, MA
0000 As of 0000
00000
00000000 00000

00000 00

bore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi
0000000000000
Philadelphia, PA
000 As of 0000
00000
0.000 0000-00-00
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Axsome Therapeutics Competitors (16)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Bluebird Bio Formerly VC-backed Cambridge, MA 0000 00000 00000000 00000
00000 000000000000 Formerly VC-backed Philadelphia, PA 000 00000 000000&0 00000
0000000 0000000000 Formerly VC-backed Burlington, MA 000 00000 00000000000 00000
0000000 (000000 00 Formerly PE-Backed Boston, MA 000 00000 000000 - 000 00000
000000 00000000000 Formerly VC-backed San Diego, CA 000 00000 000000&0
You’re viewing 5 of 16 competitors. Get the full list »

Axsome Therapeutics Executive Team (10)

Name Title Board Seat Contact Info
Herriot Tabuteau MD Chief Executive Officer & Chairman
Nick Pizzie Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Mark Jacobson Chief Operating Officer, Operations
Kevin Laliberte Executive Vice President
Lori Englebert Senior Vice President
You’re viewing 5 of 10 executive team members. Get the full list »

Axsome Therapeutics Board Members (6)

Name Representing Role Since
0000000 00000000 00 Axsome Therapeutics Chief Executive Officer & Chairman 000 0000
0000 0000000 00 Axsome Therapeutics Board Member 000 0000
0000 0000 Axsome Therapeutics Board Member 000 0000
000000 000000 Self Board Member 000 0000
00000 00000 00.0 Self Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Axsome Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial